Home / What’s new? / Patents

Patents


Patent

Preparation of Biaryls

Number
WO 2009/003650
Year
2009
Customer
Bayer Cropscience
Site
Nijmegen
Department
Development
MCS People
Eric Damen
Patent

A method for the preparation of an enantiomerically pure benzazepine

Number
WO 2008/125577
Year
2008
Customer
Organon
Site
Groningen
Department
Development
MCS People
Jean-Paul Seerden
Patent

HIV Replication Inhibiting Purine Derivatives

Number
WO 2005028479
Year
2005
Customer
Janssen Pharma-ceutica N.V. (CMD)
Site
Nijmegen
Department
Discovery
MCS People
Ruben Leenders, Dirk Vandenput
Patent

Substituted 3-pyrrolidin-indole derivatives

Number
WO 2005019208
Year
2005
Customer
Grünenthal
Site
Nijmegen
Department
Discovery
MCS People
Edward Bijsterveld
Patent

HIV Inhibiting 1,2,4-Triazines

Number
WO 2004074266
Year
2004
Customer
Janssen Pharma-ceutica N.V. (CMD)
Site
Nijmegen
Department
Discovery
MCS People
Ruben Leenders
Patent

Method of preparation of a precursor oligocene

Number
WO 2004083160 A1 20040930
Year
2004
Customer
Philips
Site
Groningen
Department
Development
MCS People
Wolter ten Hoeve
Patent

N-Phenyl-(4-pyridyl)-Azinylamine Derivatives as Plant Protection Agents

Number
WO 2004/084634
Year
2004
Customer
Syngenta
Site
Nijmegen
Department
Discovery
MCS People
Ruud Titulaer
Patent

Processes for the Preparation of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

Number
WO 2004016581
Year
2004
Customer
Janssen Pharma-ceutica N.V. (CMD)
Site
Nijmegen
Department
Discovery
MCS People
Ruben Leenders
Patent

HIV Replication Inhibitors

Number
US 20030171374
Year
2003
Customer
Janssen Pharma-ceutica N.V. (CMD)
Site
Department
MCS People
Ruben Leenders
Patent

Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer

Number
US7176315 B2
Year
2002
Customer
Pfizer Inc.
Site
Groningen
Department
Discovery
MCS People
Kees Pouwer

* indicates required



 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
 
 

Development Centres of Excellence Network Lead Optimization Hit Generation Lead Optimization
 
 
 
Scroll to top